Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Genenta Science SPASTU:K5F -0.74%39 3-1 Month Momentum % is -28.95% as of Sep. 15, 2026. GuruFocus rates STU:K5F with a GF Score™ of 39/100. The stock has 4 warning signs investors should review. Among 588 Conglomerates companies, Genenta Science SPA ranks worse than 97.45% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-15), Genenta Science SPA's 3-1 Month Momentum % is -28.95%.
The industry rank for Genenta Science SPA's 3-1 Month Momentum % or its related term are showing as below:
STU:K5F's 3-1 Month Momentum % is ranked worse than 97.45% of 588
companies
in the Conglomerates industry
Industry Median: 0.79
vs STU:K5F: -28.95
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Genenta Science SPA 3-1 Month Momentum % Related Terms
STU:K5F vs VRTX, REGN, MRNA: 3-1 Month Momentum % Comparison
For the Conglomerates subindustry, Genenta Science SPA's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genenta Science SPA 3-1 Month Momentum % vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Genenta Science SPA's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Genenta Science SPA's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genenta Science SPA (STU:K5F) has a 3-1 Month Momentum % of -28.95% as of Sep. 15, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Genenta Science SPA and its competitors. According to the industry distribution chart, Genenta Science SPA ranks #573 out of 588 companies in the Conglomerates industry, placing it in the top 97.4%.
Is Genenta Science SPA's 3-1 Month Momentum % too high?
Genenta Science SPA's current 3-1 Month Momentum % is -28.95%. Based on the distribution chart, Genenta Science SPA ranks #573 out of 588 companies in the Conglomerates industry, which is in the bottom quartile relative to peers. Overall, Genenta Science SPA has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Genenta Science SPA's 3-1 Month Momentum % compare to VRTX and REGN?
According to the Conglomerates industry distribution chart, Genenta Science SPA ranks #573 out of 588 companies for 3-1 Month Momentum %. This places Genenta Science SPA in the lower half of its industry. The industry median 3-1 Month Momentum % is 0.79. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Conglomerates company?
The median 3-1 Month Momentum % among Conglomerates companies is 0.79, based on 588 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Genenta Science SPA and its competitors. For the Conglomerates industry, the median 3-1 Month Momentum % is 0.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genenta Science SPA's current 3-1 Month Momentum % is -28.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genenta Science SPA stock overvalued right now?
Genenta Science SPA (STU:K5F) has a current 3-1 Month Momentum % of -28.95%. The current 3-1 Month Momentum % is -28.95%. Genenta Science SPA's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Genenta Science SPA (STU:K5F), the current 3-1 Month Momentum % is -28.95% as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
39GF Score
Get the complete analysis for STU:K5F
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:K5F has been successfully added to your 
